Evidence map›Paper›PMID 38682540›Full record

ArticleJournal of applied clinical medical physics2024

A deep learning-based 3D Prompt-nnUnet model for automatic segmentation in brachytherapy of postoperative endometrial carcinoma.

Xian Xue, Dazhu Liang, Kaiyue Wang, Jianwei Gao, Jingjing Ding, Fugen Zhou, Juan Xu, Hefeng Liu, Quanfu Sun, Ping Jiang and 3 more

Abstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Systematic review of artificial intelligence in brachytherapy.Journal of contemporary brachytherapy · 2026
    Review
  4. Article
  5. A review of artificial intelligence in brachytherapy.Journal of applied clinical medical physics · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Xian XueSecondary Standard Dosimetry Laboratory, National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention (CDC), Beijing, China.
Dazhu LiangDigital Health China Technologies Co., LTD, Beijing, China.
Kaiyue WangDepartment of Radiotherapy, Peking University Third Hospital, Beijing, China.
Jianwei GaoDigital Health China Technologies Co., LTD, Beijing, China.
Jingjing DingDepartment of Radiotherapy, Chinese People's Liberation Army (PLA) General Hospital, Beijing, China.
Fugen ZhouDepartment of Aero-space Information Engineering, Beihang University, Beijing, China.
Juan XuDigital Health China Technologies Co., LTD, Beijing, China.
Hefeng LiuDigital Health China Technologies Co., LTD, Beijing, China.
Quanfu SunSecondary Standard Dosimetry Laboratory, National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention (CDC), Beijing, China.
Ping JiangDepartment of Radiotherapy, Peking University Third Hospital, Beijing, China.
Laiyuan TaoDigital Health China Technologies Co., LTD, Beijing, China.
Wenzhao ShiDigital Health China Technologies Co., LTD, Beijing, China.
Jinsheng ChengSecondary Standard Dosimetry Laboratory, National Institute for Radiological Protection, Chinese Center for Disease Control and Prevention (CDC), Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo create and evaluate a three-dimensional (3D) Prompt-nnUnet module that utilizes the prompts-based model combined with 3D nnUnet for producing the rapid and consistent autosegmentation of high-risk clinical target volume (HR CTV) and organ at risk (OAR) in high-dose-rate brachytherapy (HDR BT) for patients with postoperative endometrial carcinoma (EC). METHODS AND MATERIALS: On two experimental batches, a total of 321 computed tomography (CT) scans were obtained for HR CTV segmentation from 321 patients with EC, and 125 CT scans for OARs segmentation from 125 patients. The numbers of training/validation/test were 257/32/32 and 87/13/25 for HR CTV and OARs respectively. A novel comparison of the deep learning neural network 3D Prompt-nnUnet and 3D nnUnet was applied for HR CTV and OARs segmentation. Three-fold cross validation and several quantitative metrics were employed, including Dice similarity coefficient (DSC), Hausdorff distance (HD), 95th percentile of Hausdorff distance (HD95%), and intersection over union (IoU).

resultsThe Prompt-nnUnet included two forms of parameters Predict-Prompt (PP) and Label-Prompt (LP), with the LP performing most similarly to the experienced radiation oncologist and outperforming the less experienced ones. During the testing phase, the mean DSC values for the LP were 0.96 ± 0.02, 0.91 ± 0.02, and 0.83 ± 0.07 for HR CTV, rectum and urethra, respectively. The mean HD values (mm) were 2.73 ± 0.95, 8.18 ± 4.84, and 2.11 ± 0.50, respectively. The mean HD95% values (mm) were 1.66 ± 1.11, 3.07 ± 0.94, and 1.35 ± 0.55, respectively. The mean IoUs were 0.92 ± 0.04, 0.84 ± 0.03, and 0.71 ± 0.09, respectively. A delineation time < 2.35 s per structure in the new model was observed, which was available to save clinician time.

conclusionThe Prompt-nnUnet architecture, particularly the LP, was highly consistent with ground truth (GT) in HR CTV or OAR autosegmentation, reducing interobserver variability and shortening treatment time.

Indexed as

BrachytherapyDeep LearningEndometrial NeoplasmsOrgans at RiskRadiotherapy DosageRadiotherapy Planning, Computer-AssistedTomography, X-Ray ComputedAlgorithmsFemaleHumansImage Processing, Computer-AssistedImaging, Three-DimensionalPrognosisRadiotherapy, Intensity-Modulatedautosegmentation of HR CTV or OARECHDR BTPrompt‐nnUnet deep learning (DL) model

Identifiers

PMID38682540
PMCPMC11244685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.